EICHORPublic-registry site landscape for NCT07709910, “A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis”, a Participants With Obesity and Knee Osteoarthritis study sponsored by Fujian Shengdi Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07709910 (registry record) |
| Study title | A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis |
| Sponsor | Fujian Shengdi Pharmaceutical Co., Ltd. |
| Condition(s) | Participants With Obesity and Knee Osteoarthritis |
| Phase | PHASE3 |
| Listed sites | 1 |
| Site countries | China |
Patient-friendly overview of this study: eichor.com/study/NCT07709910.
Eichor generates a preliminary site-risk snapshot for NCT07709910 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
← Eichor home · All tracked trials · Participants With Obesity and Knee Osteoarthritis studies · Weekly briefs
